Literature DB >> 25896693

Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).

P J Simner1, H Adam2, M Baxter3, M McCracken4, G Golding5, J A Karlowsky2, K Nichol6, P Lagacé-Wiens2, M W Gilmour2, D J Hoban2, G G Zhanel2.   

Abstract

Of 1,927 Enterococcus species isolates collected across Canada from 2007 to 2013, 80 (4.2%) were identified as vancomycin-resistant enterococci (VRE). VRE infections during this time tripled in Canadian hospitals, from 1.8% to 6.0% (P = 0.03). All VRE were Enterococcus faecium, with 90% possessing vanA. The prevalence of vanB decreased from 37.5% in 2007 to 0% in 2013 (P < 0.05). The VRE were multidrug resistant, but 70.6%, 86.3%, and 100% were susceptible to doxycycline, linezolid, and daptomycin, respectively.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25896693      PMCID： PMC4468682          DOI： 10.1128/AAC.00384-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Increased multi-drug resistance among the elderly on admission to the hospital--a 12-year surveillance study.

Authors:  Claudia M Denkinger; Alison D Grant; Michael Denkinger; Shiva Gautam; Erika M C D'Agata
Journal:  Arch Gerontol Geriatr       Date:  2012-06-06       Impact factor: 3.250

2.  Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013).

Authors:  X-Q Jia; F Pang; J-Z Chen; L-X Jiang
Journal:  Pathol Biol (Paris)       Date:  2014-12-29

Review 3.  Management of multidrug-resistant enterococcal infections.

Authors:  C A Arias; G A Contreras; B E Murray
Journal:  Clin Microbiol Infect       Date:  2010-06       Impact factor: 8.067

4.  Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL.

Authors:  David A Boyd; Barbara M Willey; Darlene Fawcett; Nazira Gillani; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

5.  Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.

Authors:  George G Zhanel; Heather J Adam; Melanie R Baxter; Jeff Fuller; Kimberly A Nichol; Andrew J Denisuik; Philippe R S Lagacé-Wiens; Andrew Walkty; James A Karlowsky; Frank Schweizer; Daryl J Hoban
Journal:  J Antimicrob Chemother       Date:  2013-05       Impact factor: 5.790

6.  Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China.

Authors:  M Kang; Y Xie; C He; Z X Chen; L Guo; Q Yang; J Y Liu; Y Du; Q S Ou; L L Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-24       Impact factor: 3.267

7.  Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.

Authors:  M McCracken; A Wong; R Mitchell; D Gravel; J Conly; J Embil; L Johnston; A Matlow; D Ormiston; A E Simor; S Smith; T Du; R Hizon; M R Mulvey
Journal:  J Antimicrob Chemother       Date:  2013-03-22       Impact factor: 5.790

8.  Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.

Authors:  Lalitagauri M Deshpande; Thomas R Fritsche; Gary J Moet; Douglas J Biedenbach; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2007-03-26       Impact factor: 2.803

9.  Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.

Authors:  Andrew M Ramsey; Marya D Zilberberg
Journal:  Infect Control Hosp Epidemiol       Date:  2009-02       Impact factor: 3.254

10.  Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006).

Authors:  George G Zhanel; Mel Decorby; Kim A Nichol; Patricia J Baudry; James A Karlowsky; Philippe Rs Lagace-Wiens; Melissa McCracken; Michael R Mulvey; Daryl J Hoban
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-05       Impact factor: 2.471
View more
  10 in total

Review 1.  Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?

Authors:  Ana M Guzman Prieto; Willem van Schaik; Malbert R C Rogers; Teresa M Coque; Fernando Baquero; Jukka Corander; Rob J L Willems
Journal:  Front Microbiol       Date:  2016-05-26       Impact factor: 5.640

2.  Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.

Authors:  Laura Puchter; Iris Freya Chaberny; Frank Schwab; Ralf-Peter Vonberg; Franz-Christoph Bange; Ella Ebadi
Journal:  Antimicrob Resist Infect Control       Date:  2018-01-05       Impact factor: 4.887

3.  Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model.

Authors:  Caifen Qi; Shuangli Xu; Maomao Wu; Shuo Zhu; Yanyan Liu; Hong Huang; Guijun Zhang; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2019-11-12       Impact factor: 4.003

4.  Antibiotic Resistance and Molecular Epidemiology of Vancomycin-Resistant Enterococci in a Tertiary Care Hospital in Turkey.

Authors:  Nergis Asgin; Baris Otlu
Journal:  Infect Drug Resist       Date:  2020-01-21       Impact factor: 4.003

5.  The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections.

Authors:  Olaniyi Ayobami; Niklas Willrich; Annicka Reuss; Tim Eckmanns; Robby Markwart
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

6.  Antimicrobial resistance, virulence genes and biofilm formation in Enterococcus species isolated from milk of sheep and goat with subclinical mastitis.

Authors:  Mona A El-Zamkan; Hams M A Mohamed
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

7.  Antimicrobial Resistance in Enterococcus Spp. Isolated from a Beef Processing Plant and Retail Ground Beef.

Authors:  Devin B Holman; Cassidy L Klima; Katherine E Gzyl; Rahat Zaheer; Cara Service; Tineke H Jones; Tim A McAllister
Journal:  Microbiol Spectr       Date:  2021-11-17

8.  Kisameet Clay Isolated from the Central Coast of British Columbia, Canada, Demonstrates Broad-Spectrum Antimicrobial Activity.

Authors:  George G Zhanel; James A Karlowsky
Journal:  MBio       Date:  2016-03-08       Impact factor: 7.867

9.  Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study.

Authors:  Carlos L Correa-Martínez; Annette Jurke; Janne Schmitz; Frieder Schaumburg; Stefanie Kampmeier; Alexander Mellmann
Journal:  Microorganisms       Date:  2022-01-08

10.  Distinguishing Clinical Enterococcus faecium Strains and Resistance to Vancomycin Using a Simple In-House Screening Test.

Authors:  Natkamon Saenhom; Parichart Boueroy; Peechanika Chopjitt; Rujirat Hatrongjit; Anusak Kerdsin
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.